CHARLES RIVER LABORATORIES INTERNATIONAL, INC.

Analyst Reco. Charles River Laboratories International, Inc. Deutsche Boerse AG

Equities

RV6

US1598641074

Market Closed - Deutsche Boerse AG Other stock markets 02:07:56 2024-05-10 EDT			5-day change	1st Jan Change
212.9 ^EUR	-2.38%		-0.42%	-0.56%

05-10	JPMorgan Adjusts Price Target on Charles River Laboratories International to $270 From $280	MT
05-10	Jefferies Adjusts Price Target on Charles River Laboratories International to $226 From $235	MT

Analyst Reco.

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

JPMorgan Adjusts Price Target on Charles River Laboratories International to $270 From $280	05-10	MT
Jefferies Adjusts Price Target on Charles River Laboratories International to $226 From $235	05-10	MT
Evercore ISI Adjusts Price Target on Charles River Laboratories International to $265 From $300	05-10	MT
Baird Adjusts Price Target on Charles River Laboratories International to $270 From $282	05-10	MT
Zacks Investment Research Adjusts Charles River Laboratories International's Price Target to $259 From $278	04-12	MT
Charles River Laboratories Signs Plasmid DNA Manufacturing Deal With Ship of Theseus	04-04	MT
Deutsche Bank Raises Price Target on Charles River Laboratories to $300 From $275, Keeps Buy Rating	03-22	MT
Argus Raises Price Target on Charles River Laboratories International to $290 From $200, Maintains Buy Rating	03-18	MT
Deutsche Bank Raises Charles River Laboratories International Price Target to $275 From $245, Maintains Buy Rating	02-16	MT
Morgan Stanley Raises Price Target on Charles River Laboratories International to $235 From $205, Keeps Equalweight Rating	02-16	MT
TD Cowen Adjusts Charles River Laboratories International's PT to $260 From $193, Keeps Market Perform Rating	02-15	MT
Stephens Adjusts Charles River Laboratories International's PT to $280 From $270, Keeps Overweight Rating	02-15	MT
Citigroup Adjusts Price Target on Charles River Laboratories International to $250 From $215, Maintains Neutral Rating	02-15	MT
UBS Adjusts Charles River Laboratories International Price Target to $290 From $270, Maintains Buy Rating	02-15	MT
JPMorgan Adjusts Price Target on Charles River Laboratories International to $280 From $270, Maintains Overweight Rating	02-15	MT
Baird Adjusts Price Target on Charles River Laboratories International to $268 From $252, Maintains Outperform Rating	02-15	MT
Guggenheim Downgrades Charles River Laboratories International to Neutral From Buy	02-15	MT
Futures climb after Wall St sell-off; rate-cut jitters loom	02-14	RE
UBS Adjusts Charles River Laboratories International Price Target to $270 From $215, Maintains Buy Rating	12-15	MT
Citigroup Adjusts Price Target on Charles River Laboratories to $215 From $190, Keeps Neutral Rating	12-11	MT

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Analyst Reco. Charles River Laboratories International, Inc. Deutsche Boerse AG

Equities

RV6

US1598641074

Analyst Reco.

Filters